SWA
AGIO icon

Sutton Wealth Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Sutton Wealth Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30
Closed -$1.65K – 1314
2021
Q2 		$1.65K Hold
30
– – ﹤0.01% 1185
2021
Q1 		$1.55K Hold
30
– – ﹤0.01% 1169
2020
Q4 		$1.3K Hold
30
– – ﹤0.01% 1154
2020
Q3 		$1.05K Hold
30
– – ﹤0.01% 1134
2020
Q2 		$1.6K Hold
30
– – ﹤0.01% 1080
2020
Q1 		$1.06K Hold
30
– – ﹤0.01% 1085
2019
Q4 		$1.43K Hold
30
– – ﹤0.01% 1092
2019
Q3 		$972 Buy
+30
New +$1.24K ﹤0.01% 1115
2019
Q2 		– Sell
-187
Closed -$12.6K – 1162
2019
Q1 		$12.6K Buy
+187
New +$10.9K 0.01% 726

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Sutton Wealth Advisors's AGIO Position: Q3 2021 in Review

Sutton Wealth Advisors sold out of Agios Pharmaceuticals (AGIO) in Q3 2021, closing a stake of 30 shares — an estimated $1.65K sold.

Sutton Wealth Advisors first reported a position in AGIO in Q1 2019 and held it in 9 quarters. The position peaked at $12.6K in Q1 2019. 164 funds tracked by Wall St. Rank hold AGIO as of Q3 2021.

  • Sutton Wealth Advisors reported no remaining Agios Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Sutton Wealth Advisors sold 30 Agios Pharmaceuticals shares in Q3 2021, an estimated $1.65K.
  • Sutton Wealth Advisors first reported a position in Agios Pharmaceuticals in Q1 2019 and held it in 9 quarters.
  • Sutton Wealth Advisors's Agios Pharmaceuticals position peaked at $12.6K in Q1 2019.
  • 164 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2021.

Based on Sutton Wealth Advisors's 13F filing for Q3 2021, filed 7 Nov 2023.